Mayo Clinic
The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.
Inclusion Criteria * Adults ≥18 years. * Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis. * Undergoing FDG-PET as part of standard care. * Ability to provide informed consent. Exclusion Criteria • Inability to provide informed consent.
Blood Samples will undergo exosome profiling using mass spectrometry and/or other discovery-based approaches
Verify or correct the compensation shown for this listing.